A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cytoreductive prostatectomy (CRP) improves cancer control for oligometastatic prostate cancer (PCa). While complications are comparable to other treatments, incontinence rates are higher than radical prostatectomy for localized disease.
Area Of Science
- Urology
- Oncology
- Surgical Oncology
Background
- Oligometastatic prostate cancer (PCa) presents a treatment challenge.
- The role of cytoreductive prostatectomy (CRP) in managing oligometastatic PCa requires further elucidation.
Purpose Of The Study
- To analyze the oncologic outcomes and complication rates of cytoreductive prostatectomy (CRP) for oligometastatic prostate cancer (PCa).
- To determine the role of CRP in the treatment paradigm for oligometastatic PCa.
Main Methods
- Systematic literature search across Medline, Scopus, and Web of Science.
- Primary endpoints focused on oncologic outcomes.
- Secondary endpoints included complication rates and functional results.
Main Results
- Cytoreductive prostatectomy (CRP) demonstrated improved or comparable overall survival versus no local treatment.
- Cancer-specific survival (CSS) trends favored CRP, with significant benefits observed in multiple studies.
- Postoperative urinary incontinence rates were higher with CRP compared to radical prostatectomy (RP) for localized PCa, though severe incontinence was infrequent.
Conclusions
- CRP enhances medium-term cancer control in patients with oligometastatic PCa.
- Morbidity and complication rates associated with CRP are comparable to alternative approaches.
- A higher rate of postoperative incontinence is a notable consideration following CRP compared to RP for localized disease.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.